Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2009 4
2010 3
2011 5
2012 6
2013 8
2014 5
2015 5
2016 6
2017 5
2018 9
2019 9
2020 19
2021 25
2022 29
2023 44
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Role of NAD+ in regulating cellular and metabolic signaling pathways.
Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, Haris M, Reddy R, Patay Z, Baur J, Bagga P. Amjad S, et al. Among authors: bhat aa. Mol Metab. 2021 Jul;49:101195. doi: 10.1016/j.molmet.2021.101195. Epub 2021 Feb 17. Mol Metab. 2021. PMID: 33609766 Free PMC article. Review.
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, Sharma A, Maacha S, Karedath T, Hashem S, Yasin SB, Bagga P, Reddy R, Frennaux MP, Uddin S, Dhawan P, Haris M, Macha MA. Bhat AA, et al. Cancer Commun (Lond). 2022 Aug;42(8):689-715. doi: 10.1002/cac2.12295. Epub 2022 Jul 5. Cancer Commun (Lond). 2022. PMID: 35791509 Free PMC article. Review.
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
Dagar G, Gupta A, Masoodi T, Nisar S, Merhi M, Hashem S, Chauhan R, Dagar M, Mirza S, Bagga P, Kumar R, Akil ASA, Macha MA, Haris M, Uddin S, Singh M, Bhat AA. Dagar G, et al. Among authors: bhat aa. J Transl Med. 2023 Jul 7;21(1):449. doi: 10.1186/s12967-023-04292-3. J Transl Med. 2023. PMID: 37420216 Free PMC article. Review.
Polysaccharide-Based Nanomedicines Targeting Lung Cancer.
Bhat AA, Gupta G, Alharbi KS, Afzal O, Altamimi ASA, Almalki WH, Kazmi I, Al-Abbasi FA, Alzarea SI, Chellappan DK, Singh SK, MacLoughlin R, Oliver BG, Dua K. Bhat AA, et al. Pharmaceutics. 2022 Dec 13;14(12):2788. doi: 10.3390/pharmaceutics14122788. Pharmaceutics. 2022. PMID: 36559281 Free PMC article. Review.
miRNAs as novel immunoregulators in cancer.
Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, Singh M, Bagga P, Das BC, Bedognetti D, Reddy R, Frenneaux MP, El-Rifai W, Siddiqi MA, Haris M, Macha MA. Lone SN, et al. Among authors: bhat aa. Semin Cell Dev Biol. 2022 Apr;124:3-14. doi: 10.1016/j.semcdb.2021.04.013. Epub 2021 Apr 27. Semin Cell Dev Biol. 2022. PMID: 33926791 Review.
Exploring Dysregulated Signaling Pathways in Cancer.
Nisar S, Hashem S, Macha MA, Yadav SK, Muralitharan S, Therachiyil L, Sageena G, Al-Naemi H, Haris M, Bhat AA. Nisar S, et al. Among authors: bhat aa. Curr Pharm Des. 2020;26(4):429-445. doi: 10.2174/1381612826666200115095937. Curr Pharm Des. 2020. PMID: 31939726 Review.
Claudin-1, A Double-Edged Sword in Cancer.
Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M. Bhat AA, et al. Int J Mol Sci. 2020 Jan 15;21(2):569. doi: 10.3390/ijms21020569. Int J Mol Sci. 2020. PMID: 31952355 Free PMC article. Review.
168 results